You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Byannli authorised in Britain for schizophrenia treatment

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity